{"database": "lobbying", "table": "lobbying_activities", "rows": [[2467200, "d030d77f-55ae-440f-a478-a6a343150d37", "Q2", "MEHLMAN CONSULTING, INC.", 284950, "ASSOCIATION OF ACCESSIBLE MEDICINES", 2020, "second_quarter", "PHA", "Medicaid and Medicare drug pricing.\nPrescription drug pricing.\nS.1895 - Lower Health Care Costs Act.\nH.R. 938 - BLOCKING Act of 2019\nH.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act of 2019", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-07-15T20:15:50.177000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2467200"], "units": {}, "query_ms": 89.13389302324504, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}